FLNC suppresses gastric cancer progression by stabilizing TRIM54 (Cao et al., 2022) and is linked to cytoskeletal remodeling, a process modulated by FAT1 in EMT (Guyon et al., 2003). Here, TRIM54 is linked to gastric cancer.